Insys Investors Seek Cert. In Fentanyl Stock Drop Suit
Insys Therapeutics Inc. investors urged a New York federal judge Friday to certify their putative class action accusing the pharmaceutical company of overstating its opioid spray's financial strength, a move that...To view the full article, register now.
Already a subscriber? Click here to view full article